HENDERSON, NV--(Marketwired - Mar 10, 2015) - Rx Safes, Inc. (
Rx Safes will have the opportunity to showcase its proprietary patented fingerprint Rx DrugSAFE medication lockbox products to over 300 prominent healthcare industry experts spanning the medical device, diagnostics, health & digital IT, biotech and pharma sectors.
"The MHVF event promotes networking and will be an excellent platform for the company to interact and discuss possible business and investment opportunities with professionals who are changing the face of the healthcare industry," commented Rx Safes CEO, Lorraine Yarde. "Exhibiting provides our company and products with higher visibility and my goal is to create additional company awareness and to leave the conference with qualified leads which could translate to sales, business collaborations or possible funding sources," Ms. Yarde added.
Rx Safes patented fingerprint security technology offers a viable solution not only for drug security but can also be integrated into a variety of alternative healthcare products where security and accountability is needed. To this end, the company is pursuing OEM partnerships and has established advanced contact with a number of MHVF attendees to discuss other new business opportunities where the technology can be of value.
About Rx Safes, Inc.
Rx Safes is an emerging leader in the personal and professional healthcare drug security market. Since drug abuse and drug diversion starts with unauthorized access, our products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit www.rxdrugsafe.com.
Forward-Looking Statements for RXSF:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Like us on Facebook at https://www.facebook.com/rx.drugsafe
Follow us on Twitter at https://twitter.com/RxDrugSAFE
Contact Information:
Contact:
Farialle Pacha
Account Manager
RENMARK FINANCIAL COMMUNICATIONS FINANCIERES
1140 - 121 King Street West
Toronto, ON M5H 3T9
T. 416.644.2020
Montreal Office: T. 514.939.3989
fpacha@renmarkfinancial.com
www.renmarkfinancial.com